Annotations: 2KN1

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	TNF receptor-like	8044166	3000971	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	BCMA-Tall_bind	e2kn1A1	A: few secondary structure elements	X: EGF-like	H: EGF-related	T: TNF receptor-like	F: BCMA-Tall_bind	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	4.10.1290.10	Few Secondary Structures	Irregular	Tumor necrosis factor receptor fold	Tumor necrosis factor receptor superfamily	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF09257	BCMA, TALL-1 binding (BCMA-Tall_bind)	BCMA, TALL-1 binding	Members of this family, which are predominantly found in the tumour necrosis factor receptor superfamily member 17, BCMA, are required for binding to tumour necrosis factor ligand TALL-1 [1].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Tumor necrosis factor receptor superfamily member 17	molecular transducer activity signaling receptor activity	multicellular organismal process multicellular organismal-level homeostasis leukocyte homeostasis homeostatic process immune system process homeostasis of number of cells lymphocyte homeostasis response to stimulus immune response adaptive immune response cellular response to stimulus regulation of biological process regulation of cellular process signaling multicellular organismal process multicellular organismal-level homeostasis leukocyte homeostasis homeostatic process immune system process homeostasis of number of cells lymphocyte homeostasis response to stimulus immune response adaptive immune response cellular response to stimulus regulation of biological process regulation of cellular process signaling biological regulation cellular process signal transduction cell communication cell surface receptor signaling pathway response to cytokine cytokine-mediated signaling pathway response to peptide cellular response to tumor necrosis factor response to chemical tumor necrosis factor-mediated signaling pathway cellular response to cytokine stimulus response to tumor necrosis factor	cellular anatomical structure endomembrane system cell periphery plasma membrane membrane

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR022320	Tumour necrosis factor receptor 17	Family
A	IPR015337	BCMA, TALL-1 binding	Domain
A	IPR043521	Tumor necrosis factor receptor 13C/17	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q02223	gastric carcinoma cancer exocrine pancreatic carcinoma hepatocellular carcinoma malignant colon neoplasm osteosarcoma Relapse multiple myeloma tuberculosis cutaneous lupus erythematosus gastric cancer interstitial cystitis malignant pancreatic neoplasm periodontitis sinusitis ulcerative colitis gastric carcinoma cancer exocrine pancreatic carcinoma hepatocellular carcinoma malignant colon neoplasm osteosarcoma Relapse multiple myeloma tuberculosis cutaneous lupus erythematosus gastric cancer interstitial cystitis malignant pancreatic neoplasm periodontitis sinusitis ulcerative colitis cystic fibrosis lung cancer MALT lymphoma plasma cell myeloma Sjogren syndrome

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A	CY1	Parent Component: CYS
A	NH2	RESID: AA0081 , AA0083 , AA0084 , AA0086 , AA0087 , AA0088 , AA0090 , AA0091 , AA0092 , AA0093 , AA0095 , AA0096 , AA0097 , AA0098 , AA0099 , AA0100 PSI-MOD : L-alanine amide MOD:00090 , L-asparagine amide MOD:00092 , L-aspartic acid 1-amide MOD:00093 , L-glutamine amide MOD:00095 , L-glutamic acid 1-amide MOD:00096 , glycine amide MOD:00097 , L-isoleucine amide MOD:00099 , L-leucine amide MOD:00100 , L-lysine amide MOD:00101 , L-methionine amide MOD:00102 , L-proline amide MOD:00104 , L-serine amide MOD:00105 , L-threonine amide MOD:00106 , L-tryptophan amide MOD:00107 , L-tyrosine amide MOD:00108 , L-valine amide MOD:00109

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.